Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation
Clinical trial NCT03342196 · COMPLETED
Trial details
- NCT number
- NCT03342196
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2024-06-12
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.